230 related articles for article (PubMed ID: 16130598)
21. Serum bFGF and VEGF correlate respectively with bowel wall thickness and intramural blood flow in Crohn's disease.
Di Sabatino A; Ciccocioppo R; Armellini E; Morera R; Ricevuti L; Cazzola P; Fulle I; Corazza GR
Inflamm Bowel Dis; 2004 Sep; 10(5):573-7. PubMed ID: 15472517
[TBL] [Abstract][Full Text] [Related]
22. Investigating the role of angiogenesis in systemic lupus erythematosus.
Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
[TBL] [Abstract][Full Text] [Related]
23. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
24. Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia.
Teng CL; Young JH; Hsu SL; Chou G; Kuo IT; Yu CY; Hwang GY
J Chin Med Assoc; 2006 Nov; 69(11):534-7. PubMed ID: 17116616
[TBL] [Abstract][Full Text] [Related]
25. Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.
Dudek AZ; Mahaseth H
Cancer Invest; 2005; 23(3):193-200. PubMed ID: 15945504
[TBL] [Abstract][Full Text] [Related]
26. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Ugurel S; Rappl G; Tilgen W; Reinhold U
J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
[TBL] [Abstract][Full Text] [Related]
27. Circulating endothelial cells in patients with acute myeloid leukemia.
Wierzbowska A; Robak T; Krawczyńska A; Wrzesień-Kuś A; Pluta A; Cebula B; Smolewski P
Eur J Haematol; 2005 Dec; 75(6):492-7. PubMed ID: 16313261
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of serum proangiogenic molecules in patients with de novo non-Hodgkin lymphomas.
Rujirojindakul P; Lekhakula A
ScientificWorldJournal; 2012; 2012():215231. PubMed ID: 22629121
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients.
Salven P; Orpana A; Teerenhovi L; Joensuu H
Blood; 2000 Dec; 96(12):3712-8. PubMed ID: 11090051
[TBL] [Abstract][Full Text] [Related]
30. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of serum VEGF and bFGF in children with acute leukemia].
Hong-bing H; Wen-yi X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1019-20. PubMed ID: 22125837
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.
Pavlisa G; Pavlisa G; Kusec V; Kolonic SO; Markovic AS; Jaksic B
Eur Cytokine Netw; 2010 Jun; 21(2):92-8. PubMed ID: 20504760
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma.
Dobrzycka B; Mackowiak-Matejczyk B; Kinalski M; Terlikowski SJ
Gynecol Oncol; 2013 Mar; 128(3):454-60. PubMed ID: 23206584
[TBL] [Abstract][Full Text] [Related]
34. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
[TBL] [Abstract][Full Text] [Related]
35. Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity.
Sato N; Hattori Y; Wenlin D; Yamada T; Kamata T; Kakimoto T; Okamoto S; Kawamura C; Kizaki M; Shimada N; Ote Y; Hata J; Ikeda Y
Jpn J Cancer Res; 2002 Apr; 93(4):459-66. PubMed ID: 11985797
[TBL] [Abstract][Full Text] [Related]
36. High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
Neben K; Moehler T; Egerer G; Kraemer A; Hillengass J; Benner A; Ho AD; Goldschmidt H
Clin Cancer Res; 2001 Sep; 7(9):2675-81. PubMed ID: 11555579
[TBL] [Abstract][Full Text] [Related]
37. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
[TBL] [Abstract][Full Text] [Related]
38. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
[TBL] [Abstract][Full Text] [Related]
39. [Study on the role of angiogenesis and related factors in leukemias].
Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
[TBL] [Abstract][Full Text] [Related]
40. Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes.
Cortelezzi A; Fracchiolla NS; Mazzeo LM; Silvestris I; Pomati M; Somalvico F; Bertolini F; Mancuso P; Pruneri GC; Gianelli U; Pasquini MC; Cortiana M; Deliliers GL
Leuk Lymphoma; 2005 Sep; 46(9):1345-51. PubMed ID: 16109613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
